Tarceva and Eyes - bulging - a phase IV clinical study of FDA data

Summary:

Eyes - bulging is reported as a side effect among people who take Tarceva (erlotinib hydrochloride), especially for people who are female, 40-49 old, also take Demerol, and have Osteopenia.

The phase IV clinical study analyzes which people have Eyes - bulging when taking Tarceva. It is created by eHealthMe based on reports of 30,795 people who have side effects when taking Tarceva from the FDA, and is updated regularly.

What is Tarceva?

Tarceva has active ingredients of erlotinib hydrochloride. It is often used in lung cancer. eHealthMe is studying from 31,036 Tarceva users. Check the latest studies of Tarceva.

What is Eyes - bulging?

Eyes - bulging (swelling of eyes) is found to be associated with 310 drugs and 798 conditions by eHealthMe. Check the latest studies of Eyes - bulging.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Jul, 27, 2026

30,795 people reported to have side effects when taking Tarceva.
Among them, 20 people (0.06%) have Eyes - bulging.

Among these 20 people:

What is the gender of people who have Eyes - bulging when taking Tarceva? *

female: 100 %
male: 0.0 %

What is the age of people who have Eyes - bulging when taking Tarceva? *

What are other drugs people take besides Tarceva? *

What are other side effects people have besides Eyes - bulging? *

Vision Blurred: 19 people, 95.00%
Intervertebral Disc Degeneration (spinal disc degeneration): 17 people, 85.00%
Osteitis (a general term for inflammation of bone): 17 people, 85.00%
Mastication Disorder (disease of chewing food): 17 people, 85.00%
Lymph Follicular Hypertrophy (an increase in the size of the lymph node follicles): 17 people, 85.00%
Intestinal Obstruction: 17 people, 85.00%
Intervertebral Disc Space Narrowing (spinal disc space narrowing): 17 people, 85.00%
Intervertebral Disc Disorder (spinal disc disorder): 17 people, 85.00%
High Blood Pressure: 17 people, 85.00%
Hiatal Hernia (hernia resulting from the protrusion of part of the stomach through the diaphragm): 17 people, 85.00%

What are the existing conditions these people have? *

Osteopenia (a condition where bone mineral density is lower than normal): 17 people, 85.00%
Sinusitis (inflammation of sinus): 2 people, 10.00%
Metastases To Bone (cancer spreads to bone): 2 people, 10.00%
Lung Neoplasm Malignant (cancer tumour of lung): 2 people, 10.00%
Glaucoma (increased fluid pressure in the eye with vision loss): 2 people, 10.00%

* Approximation only. Some reports may have incomplete information.

Do you take Tarceva and have Eyes - bulging?

- Check whether Eyes - bulging is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Tarceva:

Tarceva (31,036 reports)

Eyes - bulging treatments and more:

Eyes - bulging (2,449 reports)

Browse all side effects of Tarceva:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Eyes - bulging:

Eyes - bulging (310 drugs)

Browse all the conditions that are associated with Eyes - bulging:

Eyes - bulging (798 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on erlotinib hydrochloride (the active ingredients of Tarceva) and Tarceva (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.